HER2 Intermediate Breast Cancers

被引：2
|
作者：
Jensen, Kristin C. [1 ]
Nielsen, Torsten O. [2 ]
Gilks, C. Blake [2 ]
West, Robert B. [1 ]
机构：
[1] Stanford Univ, Med Ctr, Dept Pathol, Stanford, CA 94305 USA
[2] British Columbia Canc Agcy, Vancouver Coastal Res Inst, Genet Pathol Evaluat Ctr, Vancouver, BC V5Z 4E6, Canada
来源：
AMERICAN JOURNAL OF SURGICAL PATHOLOGY | 2009年 / 33卷 / 11期
关键词：
D O I：
10.1097/PAS.0b013e3181b72865
中图分类号：
R36 [病理学];
学科分类号：
100104 ;
摘要：
引用
收藏
页码：1739 / 1739
页数：1
相关论文
共 50 条
  • [1] HER2 Positive Breast Cancers with Progression
    Solanki, Malvika
    Chitambar, Christopher
    Jorns, Julie
    [J]. LABORATORY INVESTIGATION, 2019, 99
  • [2] HER2 Positive Breast Cancers with Progression
    Solanki, Malvika
    Chitambar, Christopher
    Jorns, Julie
    [J]. MODERN PATHOLOGY, 2019, 32
  • [3] The role of HER2 and HER3 in HER2-amplified cancers beyond breast cancers
    Avisek Majumder
    Manbir Sandhu
    Debarko Banerji
    Veronica Steri
    Adam Olshen
    Mark M. Moasser
    [J]. Scientific Reports, 11
  • [4] The role of HER2 and HER3 in HER2-amplified cancers beyond breast cancers
    Majumder, Avisek
    Sandhu, Manbir
    Banerji, Debarko
    Steri, Veronica
    Olshen, Adam
    Moasser, Mark M.
    [J]. SCIENTIFIC REPORTS, 2021, 11 (01) : 9091
  • [5] Activating HER2 mutations in HER2 gene amplification negative breast cancers.
    Bose, R.
    Kavuri, S. M.
    Searleman, A. C.
    Shen, W.
    Shen, D.
    Koboldt, D. C.
    Monsey, J.
    Li, S.
    Ding, L.
    Mardis, E. R.
    Ellis, M. J.
    [J]. CANCER RESEARCH, 2012, 72
  • [6] HER2 status and disparities in luminal breast cancers
    Holowatyj, Andreana N.
    Ruterbusch, Julie J.
    Ratnam, Manohar
    Gorski, David H.
    Cote, Michele L.
    [J]. CANCER MEDICINE, 2016, 5 (08): : 2109 - 2116
  • [7] Targeting HER2 heterogeneity in breast and gastrointestinal cancers
    Valenza, Carmine
    Guidi, Lorenzo
    Battaiotto, Elena
    Trapani, Dario
    Bianchi, Andrea Sartore
    Siena, Salvatore
    Curigliano, Giuseppe
    [J]. TRENDS IN CANCER, 2024, 10 (02): : 113 - 123
  • [8] HER2 0, HER2 1+and HER2 2+/FISH Negative Breast Cancers Are Biologically Different
    Mon, Khin Su
    Zhang, Hui
    Aragao, Alessa
    Tang, Ping
    [J]. LABORATORY INVESTIGATION, 2023, 103 (03) : S182 - S183
  • [9] The Bioinformatics Analysis of miRNAs Signatures Differentially Expressed in HER2(+) Versus HER2(-) Breast Cancers
    Nie, Weiwei
    Jin, Lei
    Wang, Yanru
    Wang, Zexing
    Guan, Xiaoxiang
    [J]. CANCER BIOTHERAPY AND RADIOPHARMACEUTICALS, 2013, 28 (01) : 71 - 76
  • [10] HER2 0, HER2 1+and HER2 2+/FISH Negative Primary Breast Cancers Are Biologically Distinct
    Donahue, Nolan
    Aragao, Alessa
    Gordezky, Rachel
    Haddad, Sandra
    Tang, Ping
    [J]. LABORATORY INVESTIGATION, 2024, 104 (03) : S146 - S148
12345